Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 46Unknown 16Not yet recruiting 5Terminated 4Withdrawn 3Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Breast 1

Conditions

Pain, Postoperative 3Urinary Bladder Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Ropivacaine × Clear all
NCT03906838 2019-07-18

Regional Anesthesia Block in Fibula Free Flap Reconstruction

University of Florida

Phase EARLY_PHASE1 Withdrawn
Head & Neck

Head and Neck Neoplasms, Pain, Postoperative

NCT02438852 2019-04-16

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

University of Southern California

Phase 3 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT01943240 2016-10-27

Pectoral Nerve Blockade in Mastectomy

University of New Mexico

Phase 4 Withdrawn
Breast

Breast Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡